Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Lopez

Showing results (341-350 of 369) with videos related to

Pageof 37
Sort By:
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Nature Communications|October 30, 2014
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Nature Communications|April 26, 2023
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5LChristopher J LaFargue, Paola Amero, Kyunghee Noh, et al.
Nature Communications|June 5, 2020
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2018
Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 SignalingAdrián González-González, Esperanza Muñoz-Muela, Juan A Marchal, et al.
JCI Insight|October 26, 2016
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapyLingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
Journal of the National Cancer Institute|January 29, 2016
Role of Increased n-acetylaspartate Levels in CancerBehrouz Zand, Rebecca A Previs, Niki M Zacharias, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.
Pageof 37

Showing results (341-350 of 369) with videos related to

Sort By:
Pageof 37
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Nature Communications|October 30, 2014
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Nature Communications|April 26, 2023
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5LChristopher J LaFargue, Paola Amero, Kyunghee Noh, et al.
Nature Communications|June 5, 2020
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2018
Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 SignalingAdrián González-González, Esperanza Muñoz-Muela, Juan A Marchal, et al.
JCI Insight|October 26, 2016
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapyLingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
Journal of the National Cancer Institute|January 29, 2016
Role of Increased n-acetylaspartate Levels in CancerBehrouz Zand, Rebecca A Previs, Niki M Zacharias, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.
Pageof 37